SCHEMBL31423136

SCHEMBL31423136

CCOC(=O)c1c(OC)nc2cc(C3CCC3)ccc2c1C

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
KDM4E B2RXH2 2/20 0.40
HPGD P15428 1/20 0.37
ADORA3 P0DMS8 1/20 0.36
GAA P10253 2/20 0.36
POLB P06746 1/20 0.36
TBK1 Q9UHD2 1/20 0.35
DHODH Q02127 1/20 0.35
PDE4B Q07343 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
DGAT1 O75907 1/20 0.35
LMNA P02545 2/20 0.35
MAPT P10636 1/20 0.35
GRK6 P43250 1/20 0.35
PTGFR P43088 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31423121 0.89 TP53 (0.39) ALDH1A1SMN1; SMN2KDM4EHPGDADORA3
SCHEMBL31423001 0.87 ADORA3 (0.37) ALDH1A1KDM4EHPGDADORA3GAA
SCHEMBL31423077 0.87 KDM4E (0.35) ALDH1A1SMN1; SMN2KDM4EHPGDADORA3
SCHEMBL31423157 0.81 NPC1 (0.43) ALDH1A1SMN1; SMN2KDM4EHPGDGAA
SCHEMBL31423303 0.80 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2KDM4EHPGDGAA
SCHEMBL31422777 0.79 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2KDM4EHPGDGAA
SCHEMBL21917 0.79 TSHR (0.50) ALDH1A1SMN1; SMN2KDM4EHPGDGAA
SCHEMBL31422974 0.79 RAB9A (0.41) ALDH1A1SMN1; SMN2KDM4EADORA3POLB
SCHEMBL31423006 0.78 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2KDM4EHPGDGAA
SCHEMBL31422855 0.78 KDM4E (0.40) ALDH1A1KDM4EHPGDTBK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025085233-A1 NOVEL DERIVATIVES OF QUINOLINONES, AND COMPOSITIONS AND METHODS THEREOF ENSEM THERAPEUTICS, INC. (US) 2025-04-24 WO disclosed